United States · FDA National Drug Code directory
PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0517-4300_5db1c7ab-35c2-4764-b1ae-33f44560883b
- Product NDC
- 0517-4300
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Composition / generic term
- Paclitaxel
- Labeler
- American Regent, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230502
- Source listing expiry
- 20261231
Source-listed ingredients
- PACLITAXEL — 100 mg/20mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (0517-4300-01) / 20 mL in 1 VIAL · 0517-4300-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →